|
RebetolDrug - Rebetol The trade name of the product as shown on the labeling.
Dosage -
CAPSULE; ORAL
Active Ingredient(s) -
Ribavirin
Strength -
200MG **Indicated for use and comarketed with Interferon ALFA-2B, Recombinant (INTRON A), as Rebetron Combination Therapy**
Applicant -
SCHERING PLOUGH RES
New Drug Application (NDA) Number -
020903
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Jun 3, 1998
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Schering Plough Research Institute
Rebetol
Serpate 0.25mg Tablet; Oral
Serpivite 0.25mg Tablet; Oral Metatensin #2 0.1mg;2mg Tablet; Oral Metatensin #4 0.1mg;4mg Tablet; Oral Naquival 0.1mg;4mg Tablet; Oral Trichlormethiazide W/ Reserpine 0.1mg;4mg Tablet; Oral Rebetol 200mg Capsule; Oral Rebetol 200mg **indicated For Use And Comarketed With Interferon Alfa-2b, Recombinant (intron A), As Rebetron Combination Therapy** Capsule; Oral Serpasil 1mg Tablet; Oral Serpate 0.1mg Tablet; Oral NewDrugInformation |